NZ613942A - Interleukin-1 alpha antibodies and methods of use - Google Patents
Interleukin-1 alpha antibodies and methods of useInfo
- Publication number
- NZ613942A NZ613942A NZ613942A NZ61394209A NZ613942A NZ 613942 A NZ613942 A NZ 613942A NZ 613942 A NZ613942 A NZ 613942A NZ 61394209 A NZ61394209 A NZ 61394209A NZ 613942 A NZ613942 A NZ 613942A
- Authority
- NZ
- New Zealand
- Prior art keywords
- interleukin
- methods
- amino acid
- alpha antibodies
- seq
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5758608P | 2008-05-30 | 2008-05-30 | |
US12139108P | 2008-12-10 | 2008-12-10 | |
US17835009P | 2009-05-14 | 2009-05-14 | |
NZ59423309 | 2009-06-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ613942A true NZ613942A (en) | 2015-02-27 |
Family
ID=53189449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ613942A NZ613942A (en) | 2008-05-30 | 2009-06-01 | Interleukin-1 alpha antibodies and methods of use |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ613942A (en) |
-
2009
- 2009-06-01 NZ NZ613942A patent/NZ613942A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ596295A (en) | Anti-5T4 antibodies and uses thereof | |
NZ600022A (en) | Anti CD37 antibodies | |
NZ703653A (en) | Anti-fap antibodies and methods of use | |
RS52782B (en) | High affinity human antibodies to human il-4 receptor | |
NZ716762A (en) | Specific binding proteins and uses thereof | |
NZ597466A (en) | Recombinant anti-epidermal growth factor receptor antibody compositions | |
AR083747A1 (en) | ANTI-IL-23 ANTIBODIES | |
NZ602220A (en) | Antibodies with ph dependent antigen binding | |
RS54468B1 (en) | Monoclonal antibodies against claudin-18 for treatment of cancer | |
NZ609813A (en) | Humanized anti-factor d antibodies and uses thereof | |
GEP20104991B (en) | Antibodies that bind interleukin-4 receptor | |
NZ619953A (en) | Human cytomegalovirus neutralizing antibodies and use thereof | |
CU24058B1 (en) | PCSK9 ANTAGONISTS | |
RS54133B1 (en) | Anti-il-6 antibodies, compositions, methods and uses | |
TW200635945A (en) | Antibodies against IL-13 receptor alpha 1 and uses thereof | |
NZ594968A (en) | Humanized c-kit antibody | |
ES2685823T3 (en) | Anti-CD40 antagonist antibodies | |
RU2017124859A (en) | ANTIBODIES OBTAINED BY GENETIC ENGINEERING WITH CYSTEINE REPLACEMENTS AND THEIR CONJUGATES | |
NZ716587A (en) | Antibodies specific for claudin 6 (cldn6) | |
NZ702494A (en) | Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi) | |
RS53215B (en) | Neutralising antibodies having specificity for human il-17 | |
NZ599193A (en) | Siglec 15 antibodies in treating bone loss-related disease | |
WO2005094879A3 (en) | Monoclonal antibodies specific for human ox40l (cd 134l) | |
IL209576A (en) | Il-1α abs and methods of use | |
NZ717213A (en) | Anti-pd-l1 antibodies and their use to enhance t-cell function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 01 JUN 2016 BY PIPERS Effective date: 20150610 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 JUN 2017 BY COMPUTER PACKAGES INC Effective date: 20160518 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 JUN 2018 BY COMPUTER PACKAGES INC Effective date: 20170518 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 JUN 2019 BY COMPUTER PACKAGES INC Effective date: 20180518 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 JUN 2020 BY COMPUTER PACKAGES INC Effective date: 20190518 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 JUN 2021 BY CPA GLOBAL Effective date: 20200430 |
|
ASS | Change of ownership |
Owner name: JANSSEN BIOTECH, INC., US Effective date: 20210329 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 JUN 2022 BY CPA GLOBAL Effective date: 20210430 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 JUN 2023 BY CPA GLOBAL Effective date: 20220428 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 JUN 2024 BY CPA GLOBAL Effective date: 20230504 |